MEGA PHARMA
ActiveSummary
MEGA PHARMA has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €107,902 and a net result of -€2,092. Equity is growing by about 33% per year across the filed financial years. Its solvency ranks better than 82% of 22,382 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
21-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-06
Financial
Weakest financial yearnet -€2,092
Net result drops to -€2,092, the lowest in the series.
30-01
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
30-06
Financial
Highest result from 2022 to 2025net €5,181 ▲372%
Operating result €6,492, net result €5,181, both a record.
30-06
Financial
Equity above €100,000equity €109,994 ▲101%
A profit in every financial year since 2022 builds equity to €109,994.
31-01
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-01
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.